Moderna
The mRNA-platform biotech that rose with its COVID vaccine; now betting the platform on cancer and rare disease.
Coverage of Moderna is rising : 11 signals on the latest tracked day, up 120% from its three-week baseline of 5, across 4 domains (up from 2 a week ago). That makes it the #100 most-covered of the 274 concerns we track.
If Moderna matters to your work, coverage is climbing off its baseline — worth a closer-than-usual look this week.
What’s changed
- STAT+: Pharmalittle: We’re reading about Moderna’s flu shot, a death in a gene-editing trial in China, and more · STAT News — All Content · 2026-08-07
- Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA · Reddit r/biotech · 2026-08-07
- FDA approves Moderna’s mRNA flu vaccine · Reddit r/biotech · 2026-08-07
- STAT+: Moderna launches early trial of Ebola mRNA vaccine · STAT News — All Content · 2026-08-06
- Moderna layoff? · Reddit r/biotech · 2026-08-06
- FDA approves Moderna’s mRNA flu vaccine, the first to use the technology · STAT News — All Content · 2026-08-06
What the reporting says
Across 16 tracked stories from 7 outlets, reporting on Moderna most often describes regulatory approvals (7), acquisition (1), launches or releases (1), elections (1).
It shows up alongside FDA (12).
Two steps out: AI (through FDA, 12 shared stories on the weaker link); China (through FDA, 12 shared stories on the weaker link); CMS (through FDA, 12 shared stories on the weaker link); Colorectal Cancer (through FDA, 12 shared stories on the weaker link).
Tracked since Jul 8, with coverage on 6 separate days — concentrated in Biotech Pharma.